Source: Antimicrobial agents and chemotherapy. Unidade: FM
Subjects: BACTEREMIA, PSEUDOMONAS, NEOPLASIAS, FATORES DE RISCO
ABNT
GUDIOL, C et al. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, v. 64, n. 4, 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.02494-19. Acesso em: 04 set. 2024.APA
Gudiol, C., Albasanz-Puig, A., Laporte-amargos, J., Pallares, N., Mussetti, A., Ruiz-camps, I., et al. (2020). Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 64( 4). doi:10.1128/AAC.02494-19NLM
Gudiol C, Albasanz-Puig A, Laporte-amargos J, Pallares N, Mussetti A, Ruiz-camps I, Puerta-alcalde P, Abdala E, Oltolini C, Akova M. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa [Internet]. Antimicrobial agents and chemotherapy. 2020 ; 64( 4):[citado 2024 set. 04 ] Available from: https://doi.org/10.1128/AAC.02494-19Vancouver
Gudiol C, Albasanz-Puig A, Laporte-amargos J, Pallares N, Mussetti A, Ruiz-camps I, Puerta-alcalde P, Abdala E, Oltolini C, Akova M. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa [Internet]. Antimicrobial agents and chemotherapy. 2020 ; 64( 4):[citado 2024 set. 04 ] Available from: https://doi.org/10.1128/AAC.02494-19